logo
logo

Sano Genetics Raises £8M To Connect Rare Disease Patients With Medicine Providers

Mar 28, 2022•over 3 years ago

Amount Raised

£8 Million

CambridgeBiotechnology Research

Description

Sano Genetics, a startup that has developed a platform to connect patients that have rare, chronic diseases with personalised medicine providers, has raised $11m (£8.4m) in a Series A funding round.

Company Information

Company

Sano Genetics

Location

Cambridge, Maryland, United States

About

At Sano, our mission is to accelerate the future of personalised medicine. Our patient finding and engagement services enable researchers to deliver precision medicine clinical trials at increased speed and lower cost. Sano's end-to-end Platform integrates with your existing providers and partners, including sites, medical record retrieval services, sample collection and data analysis partners, and we apply our expert knowledge to identify new and highly efficient channels for finding and engaging the patients you need to support your project.

Related People